HCCC-9810 Cells
CAD$759.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The HCCC-9810 cell line is derived from human intrahepatic cholangiocarcinoma (iCCA), which is a highly aggressive cancer originating in the biliary epithelium. This cell line has been extensively utilized to study the molecular and cellular mechanisms underpinning cholangiocarcinoma progression and treatment response. One significant focus of research involving HCCC-9810 cells has been their response to various signaling pathway modulators. For instance, the PI3K/AKT/mTOR pathway, which plays a crucial role in cell proliferation, migration, and invasion, is implicated in iCCA pathogenesis and can be targeted to potentially reduce tumor growth. Studies have shown that the HCCC-9810 cell line exhibits traits that support research into therapeutic approaches, including the role of doublecortin-like kinase 1 (DCLK1) in promoting tumorigenic behaviors such as epithelial-mesenchymal transition (EMT). The inhibition of this pathway, as observed through the administration of specific PI3K/AKT/mTOR inhibitors, can suppress cellular proliferation, invasion, and EMT processes in HCCC-9810 cells. Additionally, investigations involving mesenchymal stem cell interactions with HCCC-9810 have revealed that conditioned media from human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) can inhibit the growth of these cancer cells by inducing apoptosis and reducing proliferative capacity, partly mediated through modulation of the Wnt/β-catenin and PI3K/Akt signaling pathways. |
|---|---|
| Organism | Human |
| Tissue | Liver |
| Disease | Cholangiocarcinoma |
| Synonyms | HCCC9810, Hccc9810 |
Characteristics
| Age | Unspecified |
|---|---|
| Gender | Female |
| Ethnicity | Chinese |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | HCCC-9810 (Cytion catalog number 305476) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_6908 |
Biomolecular Data
| Tumorigenic | Yes, in nude mice |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|